Advertisement
News
Subscribe to MDT Magazine News

Cherokee Inspired Comfort Award Calls for Healthcare Professional Nominations

March 1, 2011 10:37 am | by Bio-Medicine.Org | Comments

LOS ANGELES, March 1, 2011 /- Cherokee Uniforms, a leading provider of medical scrubs, is now accepting nominations through May 31, 2011 for its annual Inspired Comfort Award . The award provides the nation an opportunity to recognize healthcare professionals for going above and beyond...

TOPICS:

Max Neeman Develops Innovative Approach for Rare Disease Studies

March 1, 2011 9:37 am | by Bio-Medicine.Org | Comments

RESEARCH TRIANGLE PARK, N.C., March 1, 2011 /- Max Neeman International has established a team of experts specialized in carrying out rare disease trials in response to sponsor demand. The team has the required expertise to develop innovative approaches to optimize complex study design....

TOPICS:

Source Precision Medicine, Inc., dba SourceMDx Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. of the firm of Finn, Warnke & Gayton, LLP

March 1, 2011 9:35 am | by Bio-Medicine.Org | Comments

WELLESLEY HILLS, Mass., March 1, 2011 /- Source Precision Medicine, Inc., dba SourceMDx ("SourceMDx") has assigned all its assets to Joseph F. Finn, Jr., C.P.A. ("Finn") of the firm Finn, Warnke & Gayton, LLP to be liquidated for the benefit of SourceMDx creditors. Source MDx® is...

TOPICS:
Advertisement

An Easier Way to Breathe Better - ICAP Ocean Tomo Announces an Advanced Medical Inhaler Design

March 1, 2011 9:34 am | by Bio-Medicine.Org | Comments

CHICAGO, March 1, 2011 /- Developed by inventor John Vito and represented by ICAP Ocean Tomo , the assets available for auction in this lot disclose an advanced medical inhaler design that is both more accurate and more convenient for the user. (Logo:  ...

TOPICS:

UPDATE: FDA Approves New Drug to Treat Chronic Obstructive Pulmonary Disease

March 1, 2011 9:34 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., March 1, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration approved roflumilast, a pill taken daily to decrease the frequency of flare-ups (exacerbations) or worsening of symptoms from severe chronic obstructive pulmonary disease (COPD). (Logo:...

TOPICS:

Abacavir - Ongoing Safety Review: Possible Increased Risk of Heart Attack

March 1, 2011 9:30 am | by U.S. Food & Drug Administration | Comments

FDA meta-analysis of clinical trials did not show an increased risk of MI associated with the use of abacavir.

TOPICS:

Spontaneous smoking cessation may be an early symptom of lung cancer, research suggests

March 1, 2011 7:38 am | by EurekAlert | Comments

(International Association for the Study of Lung Cancer) Many longtime smokers quit spontaneously with little effort shortly before their lung cancer is diagnosed, leading some researchers to speculate that sudden cessation may be a symptom of lung cancer.

TOPICS:

CROI -- Day 2: Selected highlights of NIH-supported research

March 1, 2011 7:37 am | by EurekAlert | Comments

(NIH/National Institute of Allergy and Infectious Diseases) The 18th Conference on Retroviruses and Opportunistic Infections is taking place at the Hynes Convention Center in Boston from Feb. 27 through March 2. Day two of this major HIV/AIDS research conference included the...

TOPICS:
Advertisement

Watchful waiting no longer recommended for some high-risk Barrett's esophagus patients

March 1, 2011 6:39 am | by EurekAlert | Comments

(American Gastroenterological Association) Endoscopic removal of pre-cancerous cells in patients with confirmed, high-risk Barrett's esophagus is recommended rather than surveillance, according to a new "Medical Position Statement on the Management of Barrett's Esophagus,"...

TOPICS:

IBM Expands the Institute for Electronic Government in Washington to Focus on Advancements in Analytics and Cloud Computing

March 1, 2011 6:38 am | by IBM | Comments

IBM today announced a major expansion of its Institute for Electronic Government (IEG) in Washington, D.C., adding cloud computing and analytics capabilities for public sector organizations around the world. E-mail this page Save to del.icio.us Digg this

CIM Centers at PLTW High Schools Add VEX Robotics Design System with $400,000 in SME-EF Funding

March 1, 2011 6:38 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., February 28, 2011 — Workers who have transferable skills of advanced manufacturing technology are golden for industries with little time to waste and anxious to expand their restructured companies. More

Insmed Shareholders Approve Conversion of Series B Conditional Convertible Preferred Stock and Reverse Stock Split

March 1, 2011 6:35 am | by Bio-Medicine.Org | Comments

RICHMOND, Va., March 1, 2011 /- Insmed Incorporated (Nasdaq: INSM ), a biopharmaceutical company, announced today that Insmed's shareholders approved the proposal relating to the conversion of Insmed's Series B Conditional Convertible Preferred Stock (Series B Preferred Stock) into...

TOPICS:

FDA Approves New Drug to Treat Chronic Obstructive Pulmonary Disease

March 1, 2011 6:35 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., March 1, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration approved roflumilast, a pill taken daily to decrease the frequency of flare-ups (exacerbations) or worsening of symptoms from severe chronic obstructive pulmonary disease (COPD). (Logo:...

TOPICS:

Perrigo Announces Arrival of the FDA for Reinspection Related to the Allegan Facility Warning Letter

March 1, 2011 6:34 am | by Bio-Medicine.Org | Comments

ALLEGAN, Mich., March 1, 2011 /- Perrigo (Nasdaq: PRGO;TASE) today announced that, as part of the anticipated follow-up to the warning letter Perrigo received on April 30, 2010, the Detroit Office of the Food and Drug Administration (FDA) has arrived at their Allegan facility for the...

TOPICS:

RXi raising $8.1M from public equities sale

March 1, 2011 4:37 am | by Mass High Tech: The Journal of New England Technology | Comments

RXi Pharmaceuticals Corp. of Worcester is raising $8.1 million through a public stock offering of 6 million units of combined stocks and warrants, with proceeds to be used for "general corporate purposes."

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading